Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-025104
Filing Date
2025-03-18
Accepted
2025-03-18 17:00:33
Documents
4
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm258582d4_def14a.htm DEF 14A 531160
2 GRAPHIC tm258582d1_pre14asp1img001.jpg GRAPHIC 3897
3 GRAPHIC tm258582d1_pre14aimg001.jpg GRAPHIC 152363
4 GRAPHIC tm258582d1_pre14aimg002.jpg GRAPHIC 138621
  Complete submission text file 0001104659-25-025104.txt   938847
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39752 | Film No.: 25749303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)